Diseases cause metabolic changes in the human body. So-called volatile organic compounds are the end product of such disease-associated metabolism and can be excreted through breath, blood, and urine and can be used as biomarkers. The correlation between disease and specific volatile organic biomarkers has been revealed for hundreds of disorders: diabetes, airway obstructions), infections including respiratory infections, cancer (lung cancer, breast cancer, prostate cancer, colorectal cancer), and others.
Diagnostic based on detecting volatile organic compounds is very perspective due to sampling noninvasiveness and painless procedures. Volatile organic compounds sample analysis can be performed frequently to reflect disease progression and significantly improve continuous health monitoring.
The main product advantage of Sniffer is full automation and, as a result, total integration into the user's routing processes. The “noise/dirty” toilet bowl environment and lower concentration of biomaterial are fully compensated with a vast number of data points (test events), resulting in vivid statistics, tendencies, and health insights. This is a big deal when detecting early signs of disease or changes in health conditions in the asymptomatic or presymptomatic phases.